Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Rigel J. Kishton

机构：BD Biosciences (United States), National Cancer Institute, National Cancer Institute · ORCID：0000-0002-5682-3896

发表论文 96 篇 · 总被引 10082 次 · h-index 27

代表论文

  • T cells lead the charge against solid tumors (2024 · Nature Cancer · 被引 6)
  • CRISPR Technology and Its Application in Therapeutics (2024)
  • Figure S4 from Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem Cells (2023)
  • FIGURE 6 from Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem Cells (2023)
  • Figure S3 from Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem Cells (2023)
  • FIGURE 5 from Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem Cells (2023)